Your browser doesn't support javascript.
loading
A higher burden of multiple sclerosis genetic risk confers an earlier onset.
Misicka, Elina; Davis, Mary F; Kim, Woori; Brugger, Steven W; Beales, Jeremy; Loomis, Stephanie; Bronson, Paola G; Briggs, Farren Bs.
Afiliação
  • Misicka E; Department of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
  • Davis MF; Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT, USA/Department of Biomedical Informatics, Vanderbilt University, Nashville, TN, USA.
  • Kim W; Human Target Validation Core, Translational Biology, Biogen, Boston, MA, USA.
  • Brugger SW; Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT, USA.
  • Beales J; Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT, USA.
  • Loomis S; Human Target Validation Core, Translational Biology, Biogen, Boston, MA, USA.
  • Bronson PG; Human Target Validation Core, Translational Biology, Biogen, Boston, MA, USA.
  • Briggs FB; Department of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
Mult Scler ; 28(8): 1189-1197, 2022 07.
Article em En | MEDLINE | ID: mdl-34709090
ABSTRACT

BACKGROUND:

Age at onset of multiple sclerosis (MS) is an objective, influential predictor of the evolution of MS independent of disease duration.

OBJECTIVES:

Determine the influence of MS genetic predisposition on age of onset.

METHODS:

We conducted a comprehensive investigation of MS risk variants and age at onset in 3495 non-Latinx white individuals, including for combinations of HLA-DRB1*1501 alleles and quintiles of an unweighted genetic risk score (GRS) for 198 of 200 autosomal MS risk variants that reside outside the major histocompatibility complex.

RESULTS:

The mean age at onset was 32 years, 29% were male, and 46% were HLA-DRB1*1501 carriers. For those with the greatest genetic risk burden (the highest GRS quintile with two HLA-DRB1*1501 alleles) were on average 5 years younger at onset (p = 0.002) than those with the lowest genetic risk burden (the lowest GRS quintile with no HLA-DRB1*1501 alleles). There was a strong inverse relationship between the MS genetic risk burden and age at onset of MS (p < 5 × 10-8).

CONCLUSION:

We demonstrate a significant gradient between elevated MS genetic risk burden and an earlier onset of MS, suggesting that a higher MS genetic risk burden accelerates onset of the disease.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article